StockData
Abbott Laboratories logo

Abbott Laboratories (ABT) operating KPIs

ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)

Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%

Abbott Laboratories effective Tax Rate — Non-GAAP Adjusted (%) (%)

Form 8-K Quarterly Earnings Releases

QuarterlyAnnual
Latest, Q3 2026
15.2%
Period ended Sep 30, 2026
Change on a year earlier
-1.3 pts
16.5% in Q3 2025
History
47 quarters
Since Q4 2014
Sources
39
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedEffective Tax Rate — Non-GAAP Adjusted (%) (%)Year on yearSource
Q3 2026Sep 30, 202615.2%-1.3 ptsSEC Filing (0001628280-26-066601) ↗
Q2 2026Jun 30, 202615.2%-1.3 ptsSEC Filing (0001628280-26-048377) ↗
Q1 2026Mar 31, 202615.2%-1.3 ptsSEC Filing (0001628280-26-025365) ↗
Q4 2025Dec 31, 202514.8%-0.2 ptsSEC Filing (0001628280-26-002982) ↗
Q3 2025Sep 30, 202516.5%+1.5 ptsSEC Filing (0001628280-25-045049) ↗
Q2 2025Jun 30, 202516.5%+1.5 ptsSEC Filing (0001628280-25-035135) ↗
Q1 2025Mar 31, 202516.5%+1.5 ptsSEC Filing (0001628280-25-017924) ↗
Q4 2024Dec 31, 202415.0%+1.0 ptsSEC Filing (0001628280-25-002092) ↗
Q3 2024Sep 30, 202415.0%+1.0 ptsSEC Filing (0001628280-24-042893) ↗
Q2 2024Jun 30, 202415.0%+1.0 ptsSEC Filing (0001628280-24-032182) ↗
Q1 2024Mar 31, 202415.0%+1.0 ptsSEC Filing (0001628280-24-016497) ↗
Q4 2023Dec 31, 202314.0%-2.5 ptsSEC Filing (0001628280-25-002092) ↗
Q3 2023Sep 30, 202314.0%-4.1 ptsSEC Filing (0001628280-24-042893) ↗
Q2 2023Jun 30, 202314.0%-0.5 ptsSEC Filing (0001628280-23-025156) ↗
Q1 2023Mar 31, 202314.0%-0.5 ptsSEC Filing (0001628280-23-012020) ↗
Q4 2022Dec 31, 202216.5%-0.4 ptsSEC Filing (0001628280-24-002009) ↗

Breakdown

What makes up effective tax rate — non-gaap adjusted (%)

Cite this data

StockData. (2026). Abbott Laboratories Effective Tax Rate — Non-GAAP Adjusted (%) (%), quarterly Q4 2014–Q3 2026 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/tax-rate-nongaap

See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.